pentetic acid has been researched along with Brain Damage, Chronic in 2 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takahashi, S | 1 |
Mitamura, R | 1 |
Itoh, Y | 1 |
Suzuki, N | 1 |
Okuno, A | 1 |
Meierkord, H | 1 |
Wieshmann, U | 1 |
Niehaus, L | 1 |
Lehmann, R | 1 |
2 other studies available for pentetic acid and Brain Damage, Chronic
Article | Year |
---|---|
Hashimoto encephalopathy: etiologic considerations.
Topics: Adolescent; Atrophy; Brain; Brain Damage, Chronic; Contrast Media; Female; Gadolinium DTPA; Humans; | 1994 |
Structural consequences of status epilepticus demonstrated with serial magnetic resonance imaging.
Topics: Adult; Atrophy; Brain; Brain Damage, Chronic; Brain Edema; Cerebral Cortex; Cerebral Ventricles; Chi | 1997 |